{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:39:56Z","timestamp":1793173196996,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-030857"],"award-info":[{"award-number":["INV-030857"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017046","name":"School of Medicine, University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.eclinm.2025.103100","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:45:02Z","timestamp":1739357102000},"page":"103100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children"],"prefix":"10.1016","volume":"81","author":[{"given":"Nginache","family":"Nampota-Nkomba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osward M.","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrimati","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Mapemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Misiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felistas","family":"Mwakiseghile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Ndaferankhande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bright","family":"Lipenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Oshinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4997-4570","authenticated-orcid":false,"given":"Leslie P.","family":"Jamka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melita A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-581X","authenticated-orcid":false,"given":"Matthew B.","family":"Laurens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9480-2714","authenticated-orcid":false,"given":"Kathleen M.","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.eclinm.2025.103100_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taae140","article-title":"Global burden, trends and inequalities for typhoid and paratyphoid fever among children younger than 15 years over the past 30 years","volume":"31","author":"Wang","year":"2024","journal-title":"J\u00a0Travel Med"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103100_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 - recommendations","volume":"37","year":"2019","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103100_bib4","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1016\/S2214-109X(22)00275-3","article-title":"Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial","volume":"10","author":"Nampota-Nkomba","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"19","key":"10.1016\/j.eclinm.2025.103100_bib5","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.vaccine.2023.04.014","article-title":"Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh","volume":"41","author":"Khanam","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2025.103100_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijid.2021.05.061","article-title":"Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: a randomized controlled phase 2 trial","volume":"108","author":"Sirima","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103100_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jpids\/piad058","article-title":"Durable anti-vi IgG and IgA antibody responses in 15-month-old children vaccinated with typhoid conjugate vaccine in Burkina Faso","volume":"12","author":"Ouedraogo","year":"2023","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"key":"10.1016\/j.eclinm.2025.103100_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijid.2020.10.103","article-title":"Safety and immunogenicity of co-administration of meningococcal type A and measles-rubella vaccines with typhoid conjugate vaccine in children aged 15-23 months in Burkina Faso","volume":"102","author":"Sirima","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103100_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2384760","article-title":"Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children","volume":"20","author":"Nampota-Nkomba","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103100_bib10","doi-asserted-by":"crossref","first-page":"e1561","DOI":"10.1016\/S2214-109X(21)00346-6","article-title":"Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial","volume":"9","author":"Shakya","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"10301","key":"10.1016\/j.eclinm.2025.103100_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","article-title":"Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial","volume":"398","author":"Qadri","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103100_bib12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa2035916","article-title":"Safety and efficacy of a typhoid conjugate vaccine in Malawian children","volume":"385","author":"Patel","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103100_bib13","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study","volume":"9","author":"Yousafzai","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103100_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/cid\/ciad132","article-title":"Programmatic effectiveness of a pediatric typhoid conjugate vaccine campaign in Navi Mumbai, India","volume":"77","author":"Hoffman","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"40","key":"10.1016\/j.eclinm.2025.103100_bib15","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1016\/j.vaccine.2021.08.051","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: a case-control study","volume":"39","author":"Batool","year":"2021","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.eclinm.2025.103100_bib16","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1016\/j.vaccine.2022.04.093","article-title":"Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: a matched case control study","volume":"40","author":"Lightowler","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2025.103100_bib17","article-title":"Five-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children: a cluster randomised trial","author":"Qadri","year":"2024","journal-title":"SSRN"},{"issue":"10425","key":"10.1016\/j.eclinm.2025.103100_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(23)02031-7","article-title":"Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children","volume":"403","author":"Patel","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2025.103100_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107187","article-title":"Longevity of immune response following a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan","author":"Qamar","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.eclinm.2025.103100_bib20","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/cid\/ciy1103","article-title":"Typhoid vaccine acceleration consortium Malawi: a Phase III, randomized, double-blind, controlled trial of the clinical efficacy of typhoid conjugate vaccine among children in Blantyre, Malawi","volume":"68","author":"Meiring","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10436","key":"10.1016\/j.eclinm.2025.103100_bib21","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0140-6736(24)00249-6","article-title":"The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial","volume":"403","author":"Kulkarni","year":"2024","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103100_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.inf.0000232629.72160.bb","article-title":"Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys","volume":"25","author":"Tapia","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103100_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211784","article-title":"Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine","volume":"14","author":"Medise","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103100_bib24","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.vaccine.2024.02.010","article-title":"Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age","volume":"42","author":"Bijukchhe","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103100_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41541-022-00434-8","article-title":"Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose","volume":"7","author":"Capeding","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"45","key":"10.1016\/j.eclinm.2025.103100_bib26","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2021.07.073","article-title":"Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV\u00ae) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination","volume":"39","author":"Vadrevu","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103100_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103100_bib28","doi-asserted-by":"crossref","first-page":"e1688","DOI":"10.1016\/S2214-109X(21)00370-3","article-title":"Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study","volume":"9","author":"Meiring","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"25","key":"10.1016\/j.eclinm.2025.103100_bib29","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.vaccine.2017.02.034","article-title":"Tetanus vaccines: WHO position paper, February 2017 - recommendations","volume":"36","year":"2018","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103100_bib31","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2023-0090","article-title":"Vaccination strategies, the power of the unmatched double hits","volume":"9","author":"Al-Qaisi","year":"2023","journal-title":"Future Sci OA"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103100_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.vaccine.2022.12.032","article-title":"Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness","volume":"41","author":"Burrows","year":"2023","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2025.103100_bib33","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/ofid\/ofad022","article-title":"Using typhoid conjugate vaccines to prevent disease, promote health equity, and counter drug-resistant typhoid fever","volume":"10","author":"Nampota-Nkomba","year":"2023","journal-title":"Open Forum Infect Dis"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702500032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702500032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:08:05Z","timestamp":1786219685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702500032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"alternative-id":["S258953702500032X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103100","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103100"}}